------------------------------
OMB APPROVAL
OMB Number: 3235-0145
Expires: August 31, 1999
Estimated average burden
Hours per response.......14.90
------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendments No. 2)*
Hollis Eden Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class Securities)
435902101
------------------------------------
(CUSIP Number)
12/31/98
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosure provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a current
valid OMB control number.
Page 1 of 12 pages
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 435902101
<S> <C> <C>
1. Name of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Strome Susskind Investment Management, L.P.
95-4450882
- ------------------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ------------------------------------------------------------------------------------------------------------------------
3. SEC Use Only
- ------------------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- ------------------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Beneficially -----------------------------------------------------------------------------------------------
Owned by 6. Shared Voting Power 41,666
Each Reporting -----------------------------------------------------------------------------------------------
Person With: 7. Sole Dispositive Power 0
-----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 41,666
- ------------------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 41,666
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11. Percent of Class Represented by Amount in Row (9) 0.5%
- ------------------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
- ------------------------------------------------------------------------------------------------------------------------
IA, PN
All of the shares reported herein represent Warrants that are convertible into Common Stock of the issuer.
</TABLE>
Page 2 of 12 pages
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 435902101
<S> <C> <C>
1. Name of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
SSCO, Inc.
95-4450883
- ------------------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ------------------------------------------------------------------------------------------------------------------------
3. SEC Use Only
- ------------------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- ------------------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Beneficially -----------------------------------------------------------------------------------------------
Owned by 6. Shared Voting Power 41,666
Each Reporting -----------------------------------------------------------------------------------------------
Person With: 7. Sole Dispositive Power 0
-----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 41,666
- ------------------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 41,666
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11. Percent of Class Represented by Amount in Row (9) 0.5%
- ------------------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
- ------------------------------------------------------------------------------------------------------------------------
CO, OO (Control Person)
All of the shares reported herein represent Warrants that are convertible into Common Stock of the issuer.
</TABLE>
Page 3 of 12 pages
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 435902101
<S> <C> <C>
1. Name of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Mark E. Strome
- ------------------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ------------------------------------------------------------------------------------------------------------------------
3. SEC Use Only
- ------------------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization United States
- ------------------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Beneficially -----------------------------------------------------------------------------------------------
Owned by 6. Shared Voting Power 41,666
Each Reporting -----------------------------------------------------------------------------------------------
Person With: 7. Sole Dispositive Power 0
-----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 41,666
- ------------------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 41,666
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11. Percent of Class Represented by Amount in Row (9) 0.5%
- ------------------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
- ------------------------------------------------------------------------------------------------------------------------
IN;OO (Control Person)
All of the shares reported herein represent Warrants that are convertible into Common Stock of the issuer.
</TABLE>
Page 4 of 12 pages
<PAGE>
Page 5 of 12 pages
Item 1.
(a) Name of Issuer
Hollis Eden Pharmaceuticals, Inc.
(b) Address of Issuer's Principal Executive Offices
9333 Genesee Avenue, Suite 100
San Diego, CA 92121
Item 2.
(a) Name of Person Filing
(i) Strome Susskind Investment Management, L.P. ("SSIM")
(ii) SSCO, Inc. ("SSCO")
(iii) Mark E. Strome ("Strome")
(b) Address of Principal Business office or, if None, Residence
(i) 100 Wilshire Blvd., 15th Floor, Santa Monica, CA 90401
(ii) 100 Wilshire Blvd., 15th Floor, Santa Monica, CA 90401
(iii) 100 Wilshire Blvd., 15th Floor, Santa Monica, CA 90401
(c) Citizenship
(i) SSIM: Delaware
(ii) SSCO: Delaware
(iii) Strome: United States
(d) Title of Class Securities
Common Stock (represents Warrants convertible into Common Stock)
(e) CUSIP Number
435902101
<PAGE>
Page 6 of 12 pages
Item 3. If this statement is filed pursuant to ss.ss. 240.13d-1(b), or 240.13d-2
(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15
U.S.C. 78o).
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the
Investment Company Act (15 U.S.C. 80a-8).
(e) [ ] An investment adviser in accordance with ss.240.13d-1(b)(1)
(ii)(E).
(f) [ ] An employee benefit plan or endowment fund in accordance
with ss.240.13d-1(b)(ii)(F).
(g) [ ] A parent holding company or control person in accordance
with ss.240.13d-1(b)(1)(ii)(G).
(h) [ ] A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813).
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3).
(j) [X] Group in accordance with ss.240.13d-1(b)(ii)(J).
This statement is filed by Strome Susskind Investment Management, L.P.,
an investment adviser registered under the Investment Advisers Act of
1940, its control persons, SSCO, Inc., its sole general partner, and
Mark E. Strome. (See, also, Exhibit A.)
Item 4. Ownership
Common Stock:
(a) Amount Beneficially Owned: 41,666
(b) Percent of Class: 0.5%
(c) Number of shares as to which the joint filers have:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 41,666
(iii) sole power to dispose or to direct the disposition of: 0
(iv) shared power to dispose of or to direct the disposition
of: 41,666
All of the shares reported herein represent Warrants that are
convertible into common Stock of the issuer.
<PAGE>
Page 7 of 12 pages
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class securities, check the following [X].
Item 6. Ownership of More than Five Percent on Behalf of Another Person. N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
See Exhibit A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certification:
(a) The following certification shall be included if the statement is filed
pursuant to ss. 240.13d-1(b):
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired and are held I the
ordinary course of business and were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that
purpose or effect.
SIGNATURE
Date: March 15, 1999
STROME SUSSKIND INVESTMENT
MANAGEMENT, L.P.
By SSCO, Inc., its General Partner
/s/ Jeffrey S. Lambert
------------------------------------
Jeffrey S. Lambert for SSCO, Inc.
By Power of Attorney
<PAGE>
Page 8 of 12 pages
SSCO, INC.
/s/ Jeffrey S. Lambert
------------------------------------
Jeffrey S. Lambert for SSCO, Inc.
By Power of Attorney
/s/ Jeffrey S. Lambert
------------------------------------
Jeffrey S. Lambert for Mark E. Strome
By Power of Attorney
<PAGE>
Page 9 of 12 pages
EXHIBIT A
Identification and Classification of Members of the Group
---------------------------------------------------------
Pursuant to Rule 13d-1(b)(ii)(J) and Rule 13d-1(k)(1) under the Securities and
Exchange Act of 1934, the members of the group making this joint filing are
identified and classified as follows:
Name Classification
Strome Susskind Investment Management, Investment Adviser registered under
L.P. (the "Adviser") the Investment Advisers Act of 1940
SSCO, Inc. ("General Partner") A control person due to its role as
General Partner of the Adviser.
Mark E. Strome A control person of the Adviser and
the settlor and trustee of the trust
that is Controlling Shareholder of
the General Partner.
<PAGE>
Page 10 of 12 pages
EXHIBIT B
Joint Filing Agreement Pursuant to Rule 13d-1
---------------------------------------------
This agreement is made pursuant to Rule 13d-1(b)(ii)(J) and Rule 13d-1(k)(1)
under the Securities and Exchange Act of 1934 (the "Act") by and among the
parties listed below, each referred to herein as a "Joint Filer." The Joint
Filers agree that a statement of beneficial ownership as required by Sections
13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their
behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint
filing may thereafter be amended by further joint filings. The Joint Filers
state that they each satisfy the requirements for making a joint filing under
Rule 13d-1.
Dated: March 15, 1999
STROME SUSSKIND INVESTMENT
MANAGEMENT, L.P.
By SSCO, Inc., its General Partner
/s/ Jeffrey S. Lambert
--------------------------------------
Jeffrey S. Lambert for SSCO, Inc.
By Power of Attorney
SSCO, INC.
/s/ Jeffrey S. Lambert
--------------------------------------
Jeffrey S. Lambert for SSCO, Inc.
By Power of Attorney
/s/ Jeffrey S. Lambert
--------------------------------------
Jeffrey S. Lambert for Mark E. Strome
By Power of Attorney
<PAGE>
Page 11 of 12 pages
EXHIBIT C
Disclaimer of Beneficial Ownership
----------------------------------
Hollis Eden Pharmaceuticals, Inc.
Common Stock
41,666 Shares*
SSCO, Inc. and Mark E. Strome disclaim beneficial ownership as to all shares
beneficially owned for Section 13(g) filing purposes by Strome Susskind
Investment Management, L.P., as investment adviser.
*All of the shares reported herein represent Warrants that are convertible into
common Stock of the issuer.
<PAGE>
Page 12 of 12 pages
EXHIBIT D
Power of Attorney Forms for
Schedules 13D and 13G and Forms 13F
I, Mark E. Strome in my individual capacity and as a principal of Strome
Susskind Investment Management, L.P. and SSCO, Inc., hereby appoint Jeffrey S.
Lambert as attorney-in-fact and agent, in all capacities, to execute, on my
behalf and on behalf of Strome Susskind Investment Management, L.P. and to file
with the appropriate issuers, exchanges and regulatory authorities, any and all
Schedules 13D, 13G and Forms 13F and documents relating thereto required to be
filed under the Securities and Exchange Act of 1934, including exhibits,
attachments and amendments thereto and request for confidential information
contained therein. I hereby grant to said attorney-in-fact full authority to do
every act necessary to be done in order to effectuate the same as fully, to all
intents and purposes, as I could if personally present, thereby ratifying all
that said attorneys-in-fact and agents may lawfully do or cause to be done by
virtue hereof.
I hereby execute this Power of Attorney as of this 15th day of March, 1999.
/s/ Mark E. Strome
-----------------------------------
Mark E. Strome
